TARGET PRODUCT PROFILES FOR ANTIBACTERIAL RESISTANCE DIAGNOSTICS

  28 February 2020

The WHO Target Product Profiles (TPP) document informs product developers, regulatory agencies, procurement agencies and funders on R&D and public health priorities. It is intended to facilitate the most expeditious development of products addressing the greatest and most urgent public health needs. The development of WHO TPPs follows a standardized procedure and includes a number of steps. These include (i) doing a needs assessment; (ii) constituting a scientific TPP development group (with standard WHO Declaration of Interest procedures); (iii) drafting and sharing an initial draft of the TPP with the development group; (iv) revising, posting and disseminating a new version of the TPP for public consultation for 28 days (with comment form); (v) revising and finalizing the TPP (an additional consultation step may be needed in case of significant disagreement); and (vi) posting and disseminating the final version of the TPP.

Further reading: WHO
Author(s): WHO
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed